Skip to main content
Equibles
EMED logo

EMED · Electromedical Technologies, Inc · Metrics

Track EMED — free

Use EMED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EMED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 +0.00 (+0.00%) At close · Oct 23
Rebalance outlook locked
Going-concern doubt — flagged Nov 19, 2024

Substantial doubt about the company's ability to continue as a going concern.

“These factors, among others, raise substantial doubt regarding the Company’s ability to continue as a going concern.”
View the 10-Q filed Nov 19, 2024
Market Cap
$85,504
Shares
855.04M
Volume · Oct 23 2.03M Avg daily vol (3M) 6.78M

EMED metrics

63 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.00
Market cap
$85,504

Price action

20 metrics
Price change (1W)
+0.0%
Price change (30D)
+0.0%
Price change (3M)
+0.0%
Price change (6M)
+0.0%
Price change (YTD)
-50.0%
Price change (1Y)
+0.0%
Trailing year
Price change (5Y)
-99.9%
52-week high
$0.00
52-week low
$0.00
Change from 52-week high
-50.0%
Change from 52-week low
+0.0%
Annualized volatility
559.4%
Annualized volatility (3M)
—
Beta
-1.9
RSI (14D)
47.7
Price vs SMA 50
-2.0%
Price vs SMA 200
-37.7%
Avg volume (3M)
6.78M
Relative volume
0.3
Average dollar volume
$686

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
855.04M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.2×
reciprocal yield 623.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 1,078.3%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-1,962.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.7×
reciprocal yield 58.7%
EV / revenue historical average (5Y)
2.1×
reciprocal yield 48.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
75.1%
Operating margin
-109.6%
Trailing 12 months
Net margin
-182.0%
Gross profit (TTM)
$692,231
Operating profit (TTM)
−$1.01M
Net income (TTM)
−$1.68M
Trailing 12 months
Diluted EPS (TTM)
$0.00
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
$0.00
Operating profit per diluted share (TTM)
$0.00
EBITDA per diluted share (TTM)
$0.00
Net income per diluted share (TTM)
$0.00
Operating cash flow per diluted share (TTM)
$0.00
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.00
Book value per share
$-0.01

Growth

11 metrics
Revenue growth YoY
-86.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$922,010
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+479.3%
Year over year · more shares
Revenue CAGR (3Y)
+22.3%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-295.1%
Debt / equity
—
Current ratio
0.1
EBITDA (TTM)
−$1.01M
Free cash flow (TTM)
—
Quick ratio
0.1
Interest coverage
-4.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$62,296
Latest balance sheet
Cash & equivalents
$34,809
Total assets
$568,813
Total debt
$150,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$131,211
Capital expenditures (TTM)
$0
R&D (TTM)
—
SG&A (TTM)
$1.70M
Stock compensation (TTM)
$10,500
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1715819 Visit website Investor relations